中国神经再生研究(英文版) ›› 2020, Vol. 15 ›› Issue (3): 416-424.doi: 10.4103/1673-5374.265545

• 综述:脑损伤修复保护与再生 • 上一篇    下一篇

中药天然化合物治疗缺血性卒中急性期和亚急性期的疗效

  

  • 出版日期:2020-03-15 发布日期:2020-05-26

Therapeutic potential of natural compounds from Chinese medicine in acute and subacute phases of ischemic stroke

Bei Zhang1, Kathryn E. Saatman2, Lei Chen2   

  1. 1 College of Public Health, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi Province, China
    2 Spinal Cord and Brain Injury Research Center, Department of Physiology, University of Kentucky, KY, USA
  • Online:2020-03-15 Published:2020-05-26
  • Contact: Lei Chen, MD, PhD,lei.chen@uky.edu.
  • Supported by:
    This work was supported by AHA Award 14SDG20480186 (to LC), Kentucky Spinal Cord & Head Injury Research Trust Grant 14-12A (to KES), Startup Funds from Shaanxi University of Chinese Medicine to Young Investigators (1410170078) (to BZ).

摘要: orcid: 0000-0002-1218-8704 (Lei Chen)

Abstract: Stroke is one of the leading causes of death and disability in adults worldwide, resulting in huge social and financial burdens. Extracts from herbs, especially those used in Chinese medicine, have emerged as new pharmaceuticals for stroke treatment. Here we review the evidence from preclinical studies investigating neuroprotective properties of Chinese medicinal compounds through their application in acute and subacute phases of ischemic stroke, and highlight potential mechanisms underlying their therapeutic effects. It is noteworthy that many herbal compounds have been shown to target multiple mechanisms and in combinations may exert synergistic effects on signaling pathways, thereby attenuating multiple aspects of ischemic pathology. We conclude the paper with a general discussion of the prospects for novel natural compound-based regimens against stroke.

Key words: cell death, herbal compound, immune response, ischemic stroke therapy, neuroplasticity, neuroprotection, oxidative damage, traditional Chinese medicine